Your session is about to expire
← Back to Search
Constant Routine Protocol for High Blood Pressure
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up expression of bmal1 and period 3 during a 30-hour constant routine protocol
Awards & highlights
Summary
This trial looks at how well central and peripheral circadian mechanisms work in Blacks with dipping and non-dipping systolic blood pressure.
Eligible Conditions
- High Blood Pressure
- Circadian Rhythm
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ expression of bmal1 and period 3 during a 30-hour constant routine protocol
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~expression of bmal1 and period 3 during a 30-hour constant routine protocol
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Buccal cell mRNA expression
Core body temperature amplitude
Core body temperature phase
+2 moreSecondary outcome measures
Cortisol amplitude
Cortisol phase
Trial Design
1Treatment groups
Experimental Treatment
Group I: Constant Routine ProtocolExperimental Treatment1 Intervention
Participants will be kept in constant conditions for 30 hours to observe circadian physiology in the absence of light, physical activity, and meals.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,599 Previous Clinical Trials
2,287,888 Total Patients Enrolled
American Heart AssociationOTHER
336 Previous Clinical Trials
4,935,112 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger